This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Boehringer Ingelheim Austria Gmbh, Boehringer Ingelheim Rcv Gmbh & Co. Kg. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2010
Title: The Innovations of Robert Schlegl
Introduction
Robert Schlegl is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of protein refolding and reconstitution. With a total of 2 patents, his work has implications in biochemistry and biotechnology.
Latest Patents
One of Schlegl's latest patents is a "Method for refolding a protein." This method involves mixing a protein solution with a refolding buffer under conditions that approximate ideal mixing. The process can be executed in batch mode, fed-batch mode, or continuously, allowing for on-line solubilization of inclusion bodies. Another significant patent is the "Method for reconstituting a recombinant protein to its biologically active form." This method describes a chromatographic separation process that reconstitutes a recombinant protein from a denatured state to its active form. The process effectively separates the denatured form and inactive intermediate forms from the refolded protein, which can be recycled back to the feed solution.
Career Highlights
Throughout his career, Robert Schlegl has worked with prominent companies such as Boehringer Ingelheim RCV GmbH & Co. KG and Boehringer Ingelheim Austria GmbH. His experience in these organizations has allowed him to develop and refine his innovative methods in protein science.
Collaborations
Schlegl has collaborated with notable colleagues, including Roman Necina and Alois A Jungbauer. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Robert Schlegl's contributions to the field of protein refolding and reconstitution highlight his innovative spirit and dedication to scientific advancement. His patents serve as a testament to his expertise and impact in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile